Skip to main content

Peer Review reports

From: A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma

Original Submission
25 Jul 2023 Submitted Original manuscript
16 Aug 2023 Author responded Author comments - Jin Zheng
25 Aug 2023 Author responded Author comments - Jin Zheng
Resubmission - Version 2
16 Aug 2023 Submitted Manuscript version 2
12 Sep 2023 Reviewed Reviewer Report - Fangbo Zhang
18 Sep 2023 Reviewed Reviewer Report
1 Oct 2023 Author responded Author comments - Jin Zheng
Resubmission - Version 3
1 Oct 2023 Submitted Manuscript version 3
3 Oct 2023 Author responded Author comments - Jin Zheng
Resubmission - Version 4
3 Oct 2023 Submitted Manuscript version 4
Publishing
12 Oct 2023 Editorially accepted
21 Nov 2023 Article published 10.1186/s12906-023-04213-3

You can find further information about peer review here.

Back to article page